Home / … as Partners Group launches liquid PE fund

… as Partners Group launches liquid PE fund

(Pictured: Martin Scott)

Global private equity specialist Partners Group has launched an Australian dollar unit trust for the platforms market with monthly liquidity and offering applications and redemptions prices at net asset value.

The fund is based on a seven-year-old global fund which has more than 2,500 individual positions. It also contains a lot of ‘secondaries’ in the portfolio, according to Martin Scott, managing director and head of Australia for Partners Group. “It has mezzanine and income-yielding investments… which is how we can offer that liquidity,” he said.

  • The fund – ‘the global value fund’ – has been added to the BT Super Wrap and Macquarie Wrap platforms. It has been ‘highly recommended’ by Lonsec and ‘recommended’ by Zenith.

    The underlying fund has the ability to be ‘gated’ if necessary but Partners Group has not done so since inception.

    The fund has produced outperformance of public markets of 40 per cent, net of fees, with less than half the volatility, according to the manager.

    Investor Strategy News




    Print Article

    Related
    ‘Bubble thinking’: Howard Marks on market blow-ups

    Higher starting valuations usually lead to lower returns, but the most important part of a bubble is “highly skewed psychology” – and investors remain anchored to sanity.

    David Chaplin | 10th Jan 2025 | More
    ‘Martian real estate’ and bittersweet farewells: ISN’s top 10 stories of 2024

    This year’s top 10 stories included a peek into AustralianSuper’s international equities build out in London, AMP’s move to slash employee benefits, and plenty of hard-hitting analysis of the issues that matter in institutional investment. But the real story is how readers helped shape all of that coverage.

    Lachlan Maddock | 18th Dec 2024 | More
    ‘Nothing will stop me’: Stuart Place rides 15,451 km for son’s rare disease

    Orbis’ Stuart Place is riding from Melbourne to the Moon and Back to fund a treatment for the “monster of a disease” that his youngest son was born with. The investment industry is rallying behind him.

    Lachlan Maddock | 18th Dec 2024 | More
    Popular